JP2013542942A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013542942A5 JP2013542942A5 JP2013535034A JP2013535034A JP2013542942A5 JP 2013542942 A5 JP2013542942 A5 JP 2013542942A5 JP 2013535034 A JP2013535034 A JP 2013535034A JP 2013535034 A JP2013535034 A JP 2013535034A JP 2013542942 A5 JP2013542942 A5 JP 2013542942A5
- Authority
- JP
- Japan
- Prior art keywords
- ospc
- recombinant protein
- chimeric recombinant
- region epitope
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108700023315 OspC Proteins 0.000 claims 18
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 claims 12
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 claims 12
- 125000003275 alpha amino acid group Chemical group 0.000 claims 7
- 241000589968 Borrelia Species 0.000 claims 4
- 208000016604 Lyme disease Diseases 0.000 claims 4
- 208000015181 infectious disease Diseases 0.000 claims 2
- 206010061591 Borrelia infection Diseases 0.000 claims 1
- 241000282412 Homo Species 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39487710P | 2010-10-20 | 2010-10-20 | |
| US61/394,877 | 2010-10-20 | ||
| PCT/US2011/056854 WO2012054580A2 (en) | 2010-10-20 | 2011-10-19 | Polyvalent chimeric ospc vaccinogen and diagnostic antigen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013542942A JP2013542942A (ja) | 2013-11-28 |
| JP2013542942A5 true JP2013542942A5 (enExample) | 2014-12-04 |
Family
ID=45975855
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013535034A Pending JP2013542942A (ja) | 2010-10-20 | 2011-10-19 | 多価キメラｏｓｐｃワクシノーゲンおよび診断用抗原 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US8808705B2 (enExample) |
| EP (2) | EP3029073B1 (enExample) |
| JP (1) | JP2013542942A (enExample) |
| KR (1) | KR20130125771A (enExample) |
| CN (1) | CN103339151A (enExample) |
| AU (1) | AU2011317105B2 (enExample) |
| BR (1) | BR112013009588A2 (enExample) |
| CA (1) | CA2815279C (enExample) |
| MX (2) | MX349653B (enExample) |
| WO (1) | WO2012054580A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UY34745A (es) * | 2012-04-18 | 2013-11-29 | Zoetis Llc | Vacunas y procedimientos para tratar la enfermedad de lyme en perros |
| US9562079B2 (en) | 2012-04-18 | 2017-02-07 | Zoetis Services Llc | Vaccines and methods to treat lyme disease in dogs |
| CZ2014320A3 (cs) * | 2014-05-09 | 2015-11-18 | VÝZKUMNÝ ÚSTAV VETERINÁRNÍHO LÉKAŘSTVÍ, v.v.i. | Polyepitopový antigen, vakcinační konstrukt a vakcína pro prevenci lymeské boreliózy |
| WO2016057793A1 (en) * | 2014-10-08 | 2016-04-14 | Virginia Commonwealth University | Stage specific diagnostic antigens, assay and vaccine for lyme disease |
| US11209431B2 (en) | 2015-10-06 | 2021-12-28 | Bio-Rad Laboratories, Inc. | Borrelia immunoassays and materials therefor |
| WO2025015077A1 (en) | 2023-07-10 | 2025-01-16 | Dynavax Technologies Corporation | Lyme disease vaccines comprising an adjuvant and borrelia outer surface protein a and c antigens |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6872550B1 (en) | 1991-07-11 | 2005-03-29 | Baxter Vaccine Ag | Immunogenic formulation of OspC antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigens |
| US6248562B1 (en) | 1993-11-01 | 2001-06-19 | Research Foundation State University Of New York | Chimeric proteins comprising borrelia polypeptides and uses therefor |
| US7008625B2 (en) * | 1993-11-01 | 2006-03-07 | Research Foundation Of The State University Of New York | Recombinant constructs of Borrelia burgdorferi |
| WO2000006745A1 (en) * | 1998-07-31 | 2000-02-10 | Gundersen Lutheran Medical Foundation, Inc. | Uses of the borreliacidal epitope(s) of borrelia burgdorferi outer surface protein c (ospc) as vaccine |
| US7060281B1 (en) * | 1999-06-18 | 2006-06-13 | Research Foundation Of The State University Of New York | Groups of barrelia burgdorferi and borrelia afzelii that cause lyme disease in humans |
| EP1768688A4 (en) | 2004-07-02 | 2009-09-30 | Raymond J Dattwyler | ORAL BORRELIOSE VACCINE |
| EP1957520A4 (en) * | 2005-11-29 | 2009-05-27 | Univ Virginia Commonwealth | POLYVALENTIC CHIMERIC OSPC VACCINOGEN AND DIAGNOSTIC ANTIGEN |
| CA2668405C (en) * | 2006-11-03 | 2015-05-05 | Schering-Plough Ltd. | Canine lyme disease vaccine |
| US20110262475A1 (en) * | 2008-05-02 | 2011-10-27 | Earnhart Christopher G | Lyme disease vaccine |
-
2011
- 2011-10-19 BR BR112013009588A patent/BR112013009588A2/pt not_active IP Right Cessation
- 2011-10-19 MX MX2013004482A patent/MX349653B/es active IP Right Grant
- 2011-10-19 KR KR1020137012622A patent/KR20130125771A/ko not_active Withdrawn
- 2011-10-19 CA CA2815279A patent/CA2815279C/en active Active
- 2011-10-19 EP EP15199992.7A patent/EP3029073B1/en not_active Not-in-force
- 2011-10-19 CN CN2011800611724A patent/CN103339151A/zh active Pending
- 2011-10-19 US US13/879,848 patent/US8808705B2/en not_active Expired - Fee Related
- 2011-10-19 AU AU2011317105A patent/AU2011317105B2/en not_active Ceased
- 2011-10-19 WO PCT/US2011/056854 patent/WO2012054580A2/en not_active Ceased
- 2011-10-19 EP EP11835051.1A patent/EP2630162A4/en not_active Withdrawn
- 2011-10-19 JP JP2013535034A patent/JP2013542942A/ja active Pending
- 2011-10-19 MX MX2017000917A patent/MX388945B/es unknown
-
2014
- 2014-08-01 US US14/449,721 patent/US9556239B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010166916A5 (enExample) | ||
| JP2017048194A5 (enExample) | ||
| JP2013542942A5 (enExample) | ||
| WO2015138357A3 (en) | Compositions useful in treatment of otc deficency | |
| EP3412304A3 (en) | Hla-a24 agonist epitopes of muc1-c oncoprotein and compositions and methods of use | |
| HRP20241279T1 (hr) | Pripravak koji sadrži probiotike koji prekomjerno eksprimiraju protein clpb za uporabu u liječenju pretilosti | |
| FI3501534T3 (fi) | Rokotekoostumuksia, jotka käsittävät mutatoitua tekijä h:ta sitovaa proteiinia | |
| DK2707393T3 (da) | Fusionsproteiner og kombinationsvacciner omfattende haemoph-ilus influenzae-protein e og pilin a | |
| JP2012530761A5 (enExample) | ||
| JP2010011868A5 (enExample) | ||
| WO2011110655A3 (en) | Immunogenic composition or vaccine against gram - negative bacterial, for example neiserial, infection or disease | |
| MX2018001213A (es) | Nuevos metodos para inducir una respuesta inmunitaria. | |
| UA113609C2 (xx) | Антигензв'язуючий білок, який зв'язує людський il-23 | |
| GB201206559D0 (en) | Polypeptide | |
| JP2015214545A5 (enExample) | ||
| IL213039A (en) | Human anti-angiopoietin-2 antibodies, pharmacological compounds containing these antibodies, their nucleic acids encoded, and expression vectors | |
| JP2015514132A5 (enExample) | ||
| JP2011250797A5 (enExample) | ||
| WO2012104275A3 (en) | Nanoparticles delivery systems, preparation and uses thereof | |
| JP2010088434A5 (enExample) | ||
| JP2017532343A5 (enExample) | ||
| WO2009024327A3 (en) | New proteins for use in human and animal staphylococcus infections | |
| RU2017114673A (ru) | Слитый белок, наночастица, состоящая из множества мономеров указанного слитого белка, и их применение | |
| RU2018101662A (ru) | Иммуноглобулин с одним вариабельным доменом против f-белка pcb | |
| WO2016020880A3 (en) | Angiopoietin-like 4 antibodies and methods of use |